VANGUARD GROUP INC

Holdings History for Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN)

Symbol: LPCN on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$1,781,592	221,867	0		$8.03	Q4 2025
30 Sep 2025	0%	0%	$634,539	221,867	-3,009	-1.3%	$2.86	Q3 2025
30 Jun 2025	0%	0%	$710,609	224,876	-1,400	-0.62%	$3.16	Q2 2025
31 Mar 2025	0%	0%	$719,557	226,276	+4,817		$3.18	Q1 2025
31 Dec 2024	0%	0%	$1,080,720	221,459	0		$4.88	Q4 2024
30 Sep 2024	0%	0%	$994,351	221,459	0		$4.49	Q3 2024
30 Jun 2024	0%	0%	$1,824,822	221,459	0		$8.24	Q2 2024
31 Mar 2024	0%	0%	$1,151,587	221,459	0		$5.20	Q1 2024
31 Dec 2023	0%	0%	$617,871	221,459	0		$2.79	Q4 2023
30 Sep 2023	0%	0%	$659,948	221,459	0		$2.98	Q3 2023
30 Jun 2023	0%	+0%	$1,116,154	221,459	+221,459	NEW	$5.04	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.